Literature DB >> 23264447

Long-lasting inhibitory effect of apple and orange juices, but not grapefruit juice, on OATP2B1-mediated drug absorption.

Yoshiyuki Shirasaka1, Megumi Shichiri, Yukiko Murata, Takanori Mori, Takeo Nakanishi, Ikumi Tamai.   

Abstract

Enzyme-based grapefruit juice (GFJ)-drug interactions are mainly due to mechanism-based irreversible inhibition of metabolizing enzyme CYP3A4 by GFJ components, but the transporter organic anion transporting polypeptide (OATP)2B1 is also a putative site of interaction between drugs and fruit juices (FJ) in the absorption process. Here we aimed to investigate the effect of preincubation with FJ on OATP2B1-mediated transport of drugs in vitro. When OATP2B1-expressing Xenopus oocytes were preincubated with GFJ, orange juice (OJ), or apple juice (AJ), AJ induced a remarkable decrease in OATP2B1-mediated estrone-3-sulfate uptake in a concentration-dependent manner (IC(50) = 1.5%). A similar but less potent effect was observed with OJ (IC(50) = 21%), whereas GFJ had no effect. Similar results were obtained in preincubation studies using fexofenadine. Preincubation with OJ and AJ resulted in time-dependent inhibition of OATP2B1. Again, AJ had the more potent effect; its action lasted for at least 240 minutes, suggesting that AJ irreversibly inhibits OATP2B1-mediated drug uptake. Kinetic analysis revealed that coincubation and preincubation with AJ reduced OATP2B1-mediated estrone-3-sulfate uptake via competitive and noncompetitive mechanisms, respectively. Thus, OATP2B1 is functionally impaired through both competitive and long-lasting inhibition mechanisms by AJ and OJ, but not GFJ. Interestingly, although GFJ but not AJ is able to irreversibly inhibit CYP3A4, in the case of OATP2B1, AJ but not GFJ has a long-lasting inhibitory effect. Accordingly, complex FJ-drug interactions may occur in vivo, and their clinical significance should be examined.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23264447     DOI: 10.1124/dmd.112.049635

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  7 in total

1.  Substrate- and dose-dependent drug interactions with grapefruit juice caused by multiple binding sites on OATP2B1.

Authors:  Yoshiyuki Shirasaka; Takanori Mori; Yukiko Murata; Takeo Nakanishi; Ikumi Tamai
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

2.  Effects of one-time apple juice ingestion on the pharmacokinetics of fexofenadine enantiomers.

Authors:  Yumiko Akamine; Masatomo Miura; Hisakazu Komori; Shun Saito; Hiroyuki Kusuhara; Ikumi Tamai; Ichiro Ieiri; Tsukasa Uno; Norio Yasui-Furukori
Journal:  Eur J Clin Pharmacol       Date:  2014-06-07       Impact factor: 2.953

Review 3.  Organic Anion Transporting Polypeptides: Emerging Roles in Cancer Pharmacology.

Authors:  Rachael R Schulte; Richard H Ho
Journal:  Mol Pharmacol       Date:  2019-02-19       Impact factor: 4.436

4.  Evidence of reduced oral bioavailability of paracetamol in rats following multiple ingestion of grapefruit juice.

Authors:  Nidal A Qinna; Obbei A Ismail; Tawfiq M Alhussainy; Nasir M Idkaidek; Tawfiq A Arafat
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-12-30       Impact factor: 2.441

Review 5.  Phytotherapeutics: The Emerging Role of Intestinal and Hepatocellular Transporters in Drug Interactions with Botanical Supplements.

Authors:  Ghulam Murtaza; Naveed Ullah; Farah Mukhtar; Shamyla Nawazish; Saiqa Muneer
Journal:  Molecules       Date:  2017-10-21       Impact factor: 4.411

6.  Undetectable serum lithium concentrations after coadministration of liquid lithium citrate and apple juice: A case report.

Authors:  Sundus Awan; Audrey Abelleira; Loveleen Khehra; Robin Hieber
Journal:  Ment Health Clin       Date:  2021-01-08

Review 7.  Food-drug interactions precipitated by fruit juices other than grapefruit juice: An update review.

Authors:  Meng Chen; Shu-Yi Zhou; Erlinda Fabriaga; Pian-Hong Zhang; Quan Zhou
Journal:  J Food Drug Anal       Date:  2018-02-15       Impact factor: 6.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.